Pharmaceutical Industry Information Portal

HomeNews

News

А phase III study proven the efficacy of the bevacizumab biosimilar in patients with late stages of NSCLC

New results for Phase III study of BCD-021, a bevacizumab biosimilar, were presented as a poster at the European Society for Medical Oncology (ESMO)...

Promomed Group and the Ministry of Economy, Trade and Entrepreneurship of the Republic of Mordovia signed an Agreement on the development of industrial tourism

On September 21, Biokhimik JSC (part of the Promomed Group) and the Ministry of Economy, Trade and Entrepreneurship of Mordovia signed an agreement on...

Remdeform is included into all COVID-19 treatment regimens

Remdesivir (trade name: Remdeform, MA No. ЛП-006505 of October 14, 2020г) has been included into all in-hospital treatment regimens in the 12th version of...

Areplivir developed by Promomed for the treatment of coronavirus infection received marketing authorization in Uzbekistan

Areplivir, included in the guidelines of the Ministry of Health of Russia for the treatment of COVID-19, received marketing authorization in Uzbekistan. On August 4,...

Pharmstandard-UfaVITA: Investments in the Modernisation of Production

According to the press service of the Government of the Republic of Bashkortostan, Bashkiria quadrupled its production of medicines in July this year. The...

Honorary guests of the Tyumen Oil and Gas Forum visited the hormonal plant of Pharmasyntez-Tyumen prepared for launch

On September 15, the Pharmasyntez-Tyumen hormonal plant under construction in Tyumen was visited by Yuri Borisov, Deputy Prime Minister of the Russian Federation, Vladimir...
spot_img

Expert Articles

spot_img